VERU INC. Equity Securities, FV-NI, Gain (Loss)
VERU INC. (VERU) reported Equity Securities, FV-NI, Gain (Loss) of $546.13 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-08-10
- VERU INC. equity securities, fv-ni, gain (loss) for the quarter ending 2026-06-30 was $546.13K.
- VERU INC. equity securities, fv-ni, gain (loss) for the quarter ending 2026-03-31 was $3.93M.
- VERU INC. equity securities, fv-ni, gain (loss) for the quarter ending 2025-06-30 was $0.00.
- VERU INC. equity securities, fv-ni, gain (loss) for the quarter ending 2025-03-31 was $0.00.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month |
|---|---|---|---|
| 2026-06-30 | $546.13K 10-Q · filed 2026-08-10 | $4.48M derived: sum of 2 quarters · filed 2026-08-10 | $4.36M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $3.93M 10-Q · filed 2026-05-13 | $3.81M 10-Q · filed 2026-05-13 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | -$349.08K 10-Q · filed 2026-08-10 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | -$349.08K 10-Q · filed 2026-05-13 | |
| 2024-03-31 | -$192.03K 10-Q · filed 2024-05-08 | -$571.93K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -$379.90K 10-Q · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |